Use of estradiol valerate or 17beta-estradiol in combination with dienogest for oral therapy for maintaining and/or increasing the female libido

Details for Australian Patent Application No. 2007312626 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Zeun, Susan; Zimmermann, Holger; Parke, Susanne

Agent Davies Collison Cave

Pub. Number AU-A-2007312626

PCT Pub. Number WO2008/046559

Priority 06022091.0 20.10.06 EP; 07009373.7 10.05.07 EP

Filing date 12 October 2007

Wipo publication date 24 April 2008

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 15/12 (2006.01) Drugs for genital or sexual disorders

A61P 15/18 (2006.01) Drugs for genital or sexual disorders

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/046559 Priority application(s): WO2008/046559

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007312628-Chip stack cutter devices for displacing chips in a chip stack and chip-stacking apparatuses including such cutter devices, and related methods

2007312620-Device and method for locally producing microwave plasma